Efficacy and safety of enoxaparin sodium formulated by Eurofarma versus Sanofi-Aventis (Lovenox) in patients who have undergone major abdominal surgery

Trial Profile

Efficacy and safety of enoxaparin sodium formulated by Eurofarma versus Sanofi-Aventis (Lovenox) in patients who have undergone major abdominal surgery

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Feb 2013

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Venous thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top